Trial Profile
A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2009
Price :
$35
*
At a glance
- Drugs Picoplatin (Primary) ; Picoplatin (Primary)
- Indications Cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 25 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 21 Apr 2009 Final results have been reported at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009)
- 18 Nov 2008 Final top-line results reported in a Poniard media release. Endpoints achieved.